4 hrs ago | Reuters
CVS Caremark must change pitch to save merger
When Tom Ryan orchestrated the $27 billion marriage of CVS and Caremark in 2007, he may not have imagined his sharpest critics would come back to haunt him more than two years later.
Christine Jacobs: Her tenure at Theragenics makes her the longest-serving female CEO of all U.S. companies listed on the New York Stock Exchange.
A Healthier Prognosis for Cardinal
Leaner and meaner drug-distributor Cardinal health is positioned for growth. But few on Wall Street recognize its full potential -- yet.
Sunesis' Voreloxin Receives FDA Orphan Drug Designation For Acute Myeloid Leukemia
Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials Sunesis Pharmaceuticals, Inc.
Firms seek R&D funding in face of takeover threats
Press Trust of India Posted: Saturday, Nov 07, 2009 at 2243 hrs IST Updated: Saturday, Nov 07, 2009 at 2243 hrs IST New Delhi: Concerned over the recent takeover of some firms by MNCs, the domestic pharmaceutical industry has asked the government to protect and promote it by making funds available for research and development.
DOJ Investigates Alleged Fraud By Drugmakers; Sanctions On WellCare Lifted
Main Category: Pharma Industry / Biotech Industry Also Included In: Litigation / Medical Malpractice ; Health Insurance / Medical Insurance ; Medicare / Medicaid / SCHIP Article Date: 06 Nov 2009 - 5:00 PST News outlets focus on alleged fraud in the drug and insurance industries.
CVS Caremark 3Q profit up but loses big contracts
CVS Caremark disclosed more multibillion dollar contract losses in its pharmacy benefits management business and said the head of the unit will depart.
Cardinal Health posts 1Q loss on spinoff expenses
Drug distributor Cardinal Health Inc. said Thursday it took a loss in its fiscal first quarter due to expenses from the spinoff of a former business, surgical products maker CareFusion Corp.
Mylan sues Post-Gazette for libel
Mylan Pharmaceuticals is suing the Pittsburgh Post-Gazette again, this time for libel.
Drugmakers find whistle-blowing a bitter pill to swallow
If rising costs and demanding regulators aren't enough to torment pharmaceutical executives, here's one more thing to worry about: Some of your employees might be wearing a wire.
IVAX to pay $14M fine related to kickback allegations
The U.S. Department of Justice announced Tuesday that it had settled a case with IVAX Pharmaceuticals, a Weston-based division of Teva Pharmaceutical Industries, in which IVAX will pay $14 million to resolve allegations that it paid $8 million in kickbacks to Omnicare Inc.
ICIS Chemical Business Americas
Nutritional supplement regulations worry European industry
IN THE US, manufacturers of nutritional supplements have welcomed the latest good manufacturing practice regulations and increased Food and Drug Administration enforcement as developments that will eliminate fringe manufacturers and improve the industry's overall image.
BUYINS.NET: AES, PRX, TNP, TEO, MFW, MDCI Expected To Be Higher After Earnings Releases on Friday
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Friday, November 6th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and November earnings reports.
McKesson Releases Corporate Citizenship Report and Announces McKesson ...
McKesson Corporation, the nation's oldest and largest healthcare services and IT company, today announced the release of its 2008-2009 Corporate Citizenship Report and launched the McKesson Foundation's new strategic focus on chronic disease management.
Teva net up; Copaxone, respiratory strong
Teva Pharmaceutical Industries Ltd. reported on Tuesday that third-quarter net income rose 2.9%, with 25% higher sales driven particularly by its flagship drug, Copaxone, and by its ProAir albuterol inhaler.
Zacks Analyst Blog Highlights: Bank of America, Citigroup, Motorola...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
The South Mississippi Sun Herald
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to...
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.
Former Rite Aid executive becomes Value Drug Co. president
Value Drug Co.'s new president Greg Drew. ALTOONA,A Pa. Greg Drew last week joined Value Drug Co.
Executive Moves: Watson Pharmaceuticals
R. Todd Joyce has been named senior vice president and chief financial officer of Watson Pharmaceuticals , effective immediately.
Sunesis Completes Enrollment Of Voreloxin REVEAL-1 Trial In Acute Myeloid Leukemia
Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Pharma Industry / Biotech Industry Sunesis Pharmaceuticals, Inc.
Also on Topix